170 related articles for article (PubMed ID: 30562235)
1. DEXAMETHASONE INTRAVITREAL IMPLANT FOR X-LINKED (JUVENILE) RETINOSCHISIS.
Mukhtar S; Potter SM; Khurshid SG
Retin Cases Brief Rep; 2019 Winter; 13(1):18-20. PubMed ID: 30562235
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
Kumar K; Raj P; Chandnani N; Agarwal A
Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy.
Scupola A; Abed E; Sammarco MG; Traina S; Villano A; Grimaldi G; Blasi MA
Eur J Ophthalmol; 2014; 24(5):803-7. PubMed ID: 24803155
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
Gu X; Yu X; Song S; Dai H
Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
[TBL] [Abstract][Full Text] [Related]
6. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
[TBL] [Abstract][Full Text] [Related]
9. INTRAVITREAL DEXAMETHASONE IMPLANT AS ADJUVANT TREATMENT FOR BEVACIZUMAB- AND RANIBIZUMAB-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Prospective Pilot Study.
Barikian A; Salti H; Safar A; Mahfoud ZR; Bashshur ZF
Retina; 2017 Jul; 37(7):1337-1344. PubMed ID: 27768640
[TBL] [Abstract][Full Text] [Related]
10. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
11. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex
Hodzic-Hadzibegovic D; Ba-Ali S; Valerius M; Lund-Andersen H
Acta Ophthalmol; 2017 May; 95(3):324-325. PubMed ID: 27778454
[TBL] [Abstract][Full Text] [Related]
12. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
13. Effect of aging on macular features of X-linked retinoschisis assessed with optical coherence tomography.
Menke MN; Feke GT; Hirose T
Retina; 2011 Jun; 31(6):1186-92. PubMed ID: 21386765
[TBL] [Abstract][Full Text] [Related]
14. Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment.
Garweg JG; Zandi S
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1257-65. PubMed ID: 27178087
[TBL] [Abstract][Full Text] [Related]
15. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
Tsang AC; Virgili G; Abtahi M; Gottlieb CC
Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
[TBL] [Abstract][Full Text] [Related]
17. Changes in choroidal thickness after intravitreal dexamethasone implant injection in retinal vein occlusion.
Lee EK; Han JM; Hyon JY; Yu HG
Br J Ophthalmol; 2015 Nov; 99(11):1543-9. PubMed ID: 25883084
[TBL] [Abstract][Full Text] [Related]
18. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
[TBL] [Abstract][Full Text] [Related]
19. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
